Daniel Hume's most recent trade in TG Therapeutics Inc was a trade of 14,718 Common Stock done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc | Daniel Hume | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 14,718 | 192,748 (0%) | 0% | 0 | Common Stock | |
| TG Therapeutics Inc | Daniel Hume | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Mar 2025 | 62,459 | 178,030 (0%) | 0% | 0 | Common Stock | |
| TG Therapeutics Inc | Daniel Hume | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 22,250 | 240,489 (0%) | 0% | 0 | Common Stock |